Multiple Sclerosis (MS)

  1. Mavenclad (cladribine)
    Mavenclad (cladribine)
    by Merck Serono Europe Limited
    for Multiple Sclerosis
    €2,726.40
  2. Ocrevus (ocrelizumab)
    Ocrevus (ocrelizumab)
    by Roche Registration Limited
    for Multiple Sclerosis
    €6,992.76
View as Grid List

2 Items

per page
Set Descending Direction